Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oxaliplatin Regimen”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Testing effectiveness (Phase 2)Study completedNCT03443661
What this trial is testing

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Aiping Zhou 50
Testing effectiveness (Phase 2)Study completedNCT00675012
What this trial is testing

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
AGC Biologics S.p.A. 24
Testing effectiveness (Phase 2)Ended earlyNCT02392377
What this trial is testing

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Stage IB Esophageal AdenocarcinomaStage IIA Esophageal AdenocarcinomaStage IIB Esophageal Adenocarcinoma+3 more
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01487720
What this trial is testing

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Asan Medical Center 33
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Not applicableUnknownNCT05362825
What this trial is testing

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Who this might be right for
Liver Metastasis Colon CancerSynchronous Neoplasm
Cho Ray Hospital 89
Testing effectiveness (Phase 2)UnknownNCT01237665
What this trial is testing

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Who this might be right for
Rectal Cancer
Ottawa Hospital Research Institute 15
Large-scale testing (Phase 3)Study completedNCT00062426
What this trial is testing

Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Prologue Research International
Not applicableStudy completedNCT02169908
What this trial is testing

Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin

Who this might be right for
Digestive CancerGynecological Cancer
Fondation Hôpital Saint-Joseph 35
Testing effectiveness (Phase 2)UnknownNCT00852228
What this trial is testing

Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Who this might be right for
Metastatic Colorectal CancerLiver MetastasesHepatic Lesions
Association pour la Recherche sur le Temps Biologique et la Chronothérapie 60
Not applicableStudy completedNCT02970526
What this trial is testing

Long Term Effect of Oxaliplatin Treatment in Cancer Survivors

Who this might be right for
Colorectal Cancer SurvivorsOxaliplatin RegimenAdult
University Hospital, Clermont-Ferrand 409
Testing effectiveness (Phase 2)Study completedNCT03279289
What this trial is testing

Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 170
Early research (Phase 1)Study completedNCT00446290
What this trial is testing

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Who this might be right for
Stomach Cancer
Asan Medical Center 22
Large-scale testing (Phase 3)Study completedNCT00096278
What this trial is testing

Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer

Who this might be right for
Colon AdenocarcinomaStage IIA Colon Cancer AJCC v7Stage IIB Colon Cancer AJCC v7+4 more
National Cancer Institute (NCI) 2,710
Testing effectiveness (Phase 2)Study completedNCT01876927
What this trial is testing

Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer

Who this might be right for
Gastric CancerLocally Advanced Malignant Neoplasm
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 106
Testing effectiveness (Phase 2)Looking for participantsNCT06922383
What this trial is testing

A Clinical Study of Arfolitixorin in Patients With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Isofol Medical AB 90
Testing effectiveness (Phase 2)Ended earlyNCT02316496
What this trial is testing

Rechallenge of Cetuximab Combined With Irinotecan as Third-line Chemotherapy in Patients With Metastatic Colorectal Cancer - Phase II Study

Who this might be right for
Colorectal Cancer Metastatic
GERCOR - Multidisciplinary Oncology Cooperative Group 2
Testing effectiveness (Phase 2)Study completedNCT03146377
What this trial is testing

Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Hong Kong 32
Large-scale testing (Phase 3)Study completedNCT01661270
What this trial is testing

Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 332
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Next Page